Position in FATE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$337,500
+$187,500 QoQ
Shares Held
125,000
0.0% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#51
of 155 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026National Philanthropic Trust holds $22,391,990 across 7 Biotechnology names. FATE ranks #5 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ADMA |
Adma Biologics, Inc.
|
1,195,496 | $10,006,301 | |
| 2 | INCY |
Incyte Corp
|
67,655 | $7,669,370 | |
| 3 | TECH |
BIO-TECHNE Corp
|
51,284 | $3,623,214 | |
| 4 | MRNA |
Moderna, Inc.
|
5,366 | $375,780 | |
| 5 | FATE |
Fate Therapeutics Inc
This page
|
125,000 | $337,500 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
5,000 | $275,000 | |
| 7 | BCYC |
Bicycle Therapeutics PLC
|
24,723 | $104,825 |
All Filings in FATE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,500 | 125,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $150,000 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $122,500 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $157,500 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $140,000 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $98,750 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $206,250 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $437,500 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2024-06-30 | $410,000 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2024-03-31 | $917,500 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2023-12-31 | $467,500 | 125,000 | Shares | Sole | 2026-06-12 | |
| No filing history on record for this holder in this stock. | ||||||